Wyden Statement on Alex Azar Nomination to Lead HHS

Ranking Democrat Calls for Commitments to Implement Affordable Care Act, Tackle High Prescription Drug Prices

Washington, D.C. – Senate Finance Committee Ranking Member Sen. Ron Wyden, D-Ore., today issued the following statement after the announcement of Alex Azar’s nomination to lead the Department of Health and Human Services (HHS).

“The Trump administration’s track record on health care to date is objectively abysmal,” Wyden said. “At every turn, the president has broken his promises to American families to lower health care costs, expand access, and bring down the high price of prescription drugs. Trump’s previous leader at HHS, Tom Price, abused the public trust on multiple occasions, led efforts to sabotage the Affordable Care Act, and enabled congressional Republicans’ disastrous attempts to pass Trumpcare.” 

“I will closely scrutinize Mr. Azar’s record and ask for his commitment to faithfully implement the Affordable Care Act and take decisive, meaningful action to curtail the runaway train of prescription drug costs. Health care is too personal to be driven by politics, but that is what the leadership of HHS has offered so far.”

###

• Print
• Email
• Tweet